Concentrix (NASDAQ:CNXC) Issues FY 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 10.830-11.180 for the period, compared to the consensus earnings per share estimate of 11.450. The company issued revenue guidance of $9.9 billion-$10.0 billion, compared to the consensus revenue estimate of $10.1 billion. Concentrix also updated its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Stock Performance

Shares of CNXC stock traded up $0.23 on Monday, reaching $25.23. The stock had a trading volume of 3,243,255 shares, compared to its average volume of 1,609,831. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.17, a P/E/G ratio of 0.31 and a beta of 0.43. The firm’s 50-day moving average is $25.93 and its two-hundred day moving average is $32.17. Concentrix has a 12 month low of $22.05 and a 12 month high of $62.14.

Wall Street Analyst Weigh In

CNXC has been the subject of several analyst reports. Canaccord Genuity Group dropped their price objective on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, March 25th. Wall Street Zen cut shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Robert W. Baird dropped their price target on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research report on Wednesday, March 25th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Finally, Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Concentrix in a report on Monday, June 22nd. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $44.33.

Insider Activity at Concentrix

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This trade represents a 68.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Andre S. Valentine acquired 2,500 shares of the stock in a transaction dated Thursday, April 9th. The stock was bought at an average price of $27.95 per share, with a total value of $69,875.00. Following the purchase, the chief financial officer directly owned 89,066 shares in the company, valued at $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in CNXC. AQR Capital Management LLC boosted its stake in Concentrix by 1.8% during the 3rd quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock valued at $202,175,000 after purchasing an additional 75,352 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Concentrix by 28.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after buying an additional 551,778 shares during the last quarter. State Street Corp increased its stake in shares of Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock worth $85,776,000 after purchasing an additional 130,529 shares during the last quarter. First Trust Advisors LP raised its stake in shares of Concentrix by 37.7% in the fourth quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock valued at $33,509,000 after buying an additional 220,590 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Concentrix by 157.1% during the fourth quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock valued at $29,512,000 after purchasing an additional 433,731 shares during the last quarter. 90.34% of the stock is owned by institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.